|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Department of Paediatric Gastroenterology and Nutrition, The Medical University of Warsaw, Warsaw, Poland (HS and AH), and Dr von Hauner Children's Hospital, Ludwig Maximilians University of Munich, Munich, Germany (BK)
Background: It is hypothesized that the intake of long-chain polyunsaturated fatty acids (LC-PUFAs) throughout pregnancy is important to maternal health and fetal and infant development.
Objective: The objective was to evaluate systematically the effect of LC-PUFA supplementation of pregnant women's diets on pregnancy outcomes and growth measures at birth.
Design: We searched MEDLINE, EMBASE, CINAHL, and the Cochrane Library through August 2005 and also searched the references in reviewed articles for randomized controlled trials (RCTs) comparing LC-PUFA supplementation with placebo or no supplementation.
Results: Of 6 included RCTs, only 1 was judged to be at low risk of bias. Supplementation with n3 LC-PUFAs in these 6 RCTs (1278 infants) was associated with a significantly greater length of pregnancy [weighted mean difference (WMD): 1.57 d; 95% CI: 0.35, 2.78 d; findings stable on sensitivity analysis] than in control subjects. We found no evidence that supplementation influenced the percentage of preterm deliveries, the rate of low-birth-weight infants, or the rate of preeclampsia or eclampsia. We found no significant difference in the 6 RCTs (1278 infants) in birth weight (WMD: 54 g; 95% CI: 3.1, 111 g) and no significant difference in 5 RCTs (1262 infants) in birth length (WMD: 0.23 cm; 95% CI: 0.04, 0.5 cm), but, in 4 RCTs (729 infants), there was a significant increase in head circumference (WMD: 0.26 cm; 95% CI: 0.02, 0.49 cm; significance was lost on sensitivity analysis).
Conclusions: n3 LC-PUFA supplementation during pregnancy may enhance pregnancy duration and head circumference, but the mean effect size is small. The implications of these findings for later growth and development remain to be elucidated.
Key Words: Nutrition feeding development long-chain polyunsaturated fatty acids supplementation pregnancy
This article has been cited by other articles:
![]() |
M. van Eijsden, G. Hornstra, M. F van der Wal, T. G. Vrijkotte, and G. J Bonsel Maternal n-3, n-6, and trans fatty acid profile early in pregnancy and term birth weight: a prospective cohort study Am. J. Clinical Nutrition, April 1, 2008; 87(4): 887 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G Lemay, A. M Zivkovic, and J B. German Building the bridges to bioinformatics in nutrition research Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1261 - 1269. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Dubnov-Raz, Y. Finkelstein, and G. Koren Response Can Fam Physician, August 1, 2007; 53(8): 1300 - 1300. [Full Text] [PDF] |
||||
![]() |
S. Krauss-Etschmann, R. Shadid, C. Campoy, E. Hoster, H. Demmelmair, M. Jimenez, A. Gil, M. Rivero, B. Veszpremi, T. Decsi, et al. Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1392 - 1400. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Makrides and R. A. Gibson Marine Oil Supplements for Pregnant Women: Good for Mum, Good for Baby? NeoReviews, April 1, 2007; 8(4): e152 - e158. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |